Streamlining Skyrizi Prior Authorization Workflows

Klivira automates the complex Skyrizi prior authorization process, integrating directly with your EMR to minimize administrative burden and accelerate patient access to risankizumab therapy.

Managing prior authorizations for high-cost specialty medications like Skyrizi (risankizumab) presents significant operational challenges for revenue cycle teams and prior authorization coordinators. The manual effort involved in gathering clinical documentation and submitting payer-specific forms often leads to delays, staff burnout, and potential treatment interruptions for patients with plaque psoriasis, psoriatic arthritis, or Crohn's disease. Klivira provides a robust solution to streamline these critical workflows.

Addressing the Complexity of Skyrizi Prior Authorizations

Skyrizi, an IL-23 inhibitor, is indicated for serious conditions such as plaque psoriasis, psoriatic arthritis, and Crohn's disease, necessitating comprehensive clinical documentation for prior authorization. Payer policies often vary significantly across these indications, requiring precise data extraction from EMRs and adherence to specific submission protocols. This complexity can strain resources and delay patient access to this vital medication.

Automating Skyrizi Prior Authorization with Klivira

Klivira leverages advanced integration capabilities, including SMART on FHIR, to extract necessary patient and clinical data directly from your EMR. Our platform intelligently maps this information to payer-specific requirements, generating and submitting prior authorization requests via channels like X12 278, ePA, and NCPDP SCRIPT. This automation significantly reduces manual data entry and accelerates the submission process for risankizumab.

Operational Benefits for Your Prior Authorization Team

Reduced manual data entry and administrative burden for Skyrizi PAs.
Accelerated submission and approval cycles for risankizumab.
Improved data accuracy and consistency, minimizing resubmissions.
Enhanced staff productivity, allowing focus on complex cases and appeals.
Greater transparency into prior authorization status across all Skyrizi requests.

Supporting Diverse Skyrizi Indications

Whether for plaque psoriasis, psoriatic arthritis, or Crohn's disease, Klivira's platform is configured to handle the distinct clinical criteria and documentation requirements for each Skyrizi indication. Our system ensures that the correct diagnostic codes, treatment history, and supporting evidence are included in every prior authorization submission, aligning with payer medical policies.

Seamless EMR and Payer Portal Integration

Klivira is built for interoperability, offering robust integration with leading EMR systems and direct connections to payer portals. By adhering to industry standards like Da Vinci PAS, we ensure a smooth flow of information, minimizing disruptions to existing workflows. This connectivity is crucial for efficiently managing Skyrizi prior authorizations across various healthcare settings.

Frequently asked questions

What clinical data does Klivira utilize for Skyrizi prior authorizations?

Klivira extracts relevant clinical data directly from your EMR, including diagnosis codes, treatment history, lab results, imaging reports, and physician notes. This comprehensive data set ensures that all payer requirements for Skyrizi (risankizumab) are met, supporting a complete and accurate prior authorization submission.

How does Klivira handle payer-specific requirements for Skyrizi?

Our platform incorporates a dynamic rules engine that is continuously updated with the latest payer medical policies and formularies for Skyrizi. This ensures that each prior authorization request is tailored to the specific requirements of the patient's insurance plan, reducing the likelihood of denials due to incomplete or incorrect information.

Is Klivira's process for Skyrizi prior authorizations compliant with HIPAA?

Yes, Klivira is designed with robust security measures to protect ePHI throughout the entire prior authorization workflow. We adhere to stringent HIPAA compliance standards, ensuring that all patient data handled during the Skyrizi prior authorization process is secured, encrypted, and accessed only by authorized personnel.

Can Klivira integrate with my existing EMR system for Skyrizi prior authorizations?

Klivira offers extensive integration capabilities with a wide range of EMR systems, including those commonly used in dermatology and gastroenterology practices. Our integration specialists work with your IT team to establish a seamless connection, leveraging standards like SMART on FHIR to optimize data exchange for Skyrizi prior authorizations.

What support does Klivira offer if a Skyrizi prior authorization is denied?

While Klivira significantly reduces denial rates by ensuring accurate initial submissions, our platform also supports efficient appeals management. It provides tools to track denial reasons, gather additional documentation, and streamline the resubmission process, helping your team navigate the appeals for Skyrizi (risankizumab) with greater ease.